How is the NeuroSense Therapeutics Ltd today?

The NeuroSense Therapeutics Ltd today is trading in the down by -0.67% at 1.49.

What is NeuroSense Therapeutics Ltd Annual Net Profit?

NeuroSense Therapeutics Ltd Annual Net Profit fell 1.02% in the last year to $10.21 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is NeuroSense Therapeutics Ltd Price to Earning Ratio?

NeuroSense Therapeutics Ltd Price to Earning Ratio is -3.5, which is negative.

What is NeuroSense Therapeutics Ltd Stock Price?

NeuroSense Therapeutics Ltd Stock Price rose 18.25% and outperformed its sector by 7% in the past year.

What is NeuroSense Therapeutics Ltd Quarterly Net profit?

NeuroSense Therapeutics Ltd Quarterly Net profit rose 43.49% YoY to $1.8 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is NeuroSense Therapeutics Ltd Debt to Equity Ratio?

NeuroSense Therapeutics Ltd Debt to Equity Ratio of 0.03 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is NeuroSense Therapeutics Ltd Return on Equity(ROE)?

NeuroSense Therapeutics Ltd Return on Equity(ROE) for the last financial year was -2,478.16%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is NeuroSense Therapeutics Ltd Mutual Fund Holding?

NeuroSense Therapeutics Ltd Mutual Fund Holding decreased by 0% in the last quarter to 0.07.

What is NeuroSense Therapeutics Ltd Institutional Holding?

NeuroSense Therapeutics Ltd Institutional Holding decreased by 0% in the last quarter to 2.69.

NeuroSense Therapeutics Ltd XNAS: NRSN

NeuroSense Therapeutics Ltd Live Share Price Today, Share Analysis and Chart

Name: NeuroSense Therapeutics Ltd: Is Infosys Ltd. worth buying?
Item: NeuroSense Therapeutics Ltd
Rating: 1.58908325
Author: Trendlyne DVM scores

about

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, ...

1.49 -0.01 (-0.67%)

New 52W High in past week

186.2K XNAS Volume

High vol.+gain this week

XNAS 22 May, 2025 3:45 PM (EDT)

Not Eligible

-

Expensive Valuation

1.3 / 100

Technically Moderately Bullish

62.2 / 100

No estimates available

NeuroSense Therapeutics Ltd Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

NeuroSense Therapeutics Ltd FAQ

How is NeuroSense Therapeutics Ltd today?

NeuroSense Therapeutics Ltd today is trading in the red, and is down by -0.67% at 1.49.

How has NeuroSense Therapeutics Ltd performed historically?

NeuroSense Therapeutics Ltd is currently trading down -0.67% on an intraday basis. In the past week the stock rose 22.13%. stock has been up 36.70% in the past quarter and rose 18.25% in the past year. You can view this in the overview section.